DK0917460T3 - Cyclosporin-formulering - Google Patents

Cyclosporin-formulering

Info

Publication number
DK0917460T3
DK0917460T3 DK97934627T DK97934627T DK0917460T3 DK 0917460 T3 DK0917460 T3 DK 0917460T3 DK 97934627 T DK97934627 T DK 97934627T DK 97934627 T DK97934627 T DK 97934627T DK 0917460 T3 DK0917460 T3 DK 0917460T3
Authority
DK
Denmark
Prior art keywords
pct
sec
date
cyclosporin
pub
Prior art date
Application number
DK97934627T
Other languages
Danish (da)
English (en)
Inventor
Kvetoslava Benesova
Alexander Jegorov
Ales Husek
Vladimir Matha
Josef Stuchlik
Tomas Andrysek
Milan Stuchlik
Original Assignee
Ivax Cr A S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ivax Cr A S filed Critical Ivax Cr A S
Application granted granted Critical
Publication of DK0917460T3 publication Critical patent/DK0917460T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK97934627T 1996-08-01 1997-07-31 Cyclosporin-formulering DK0917460T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ19962289A CZ288739B6 (cs) 1996-08-01 1996-08-01 Cyklosporin obsahující léčivé přípravky
PCT/GB1997/002079 WO1998005309A1 (en) 1996-08-01 1997-07-31 Cyclosporin formulation

Publications (1)

Publication Number Publication Date
DK0917460T3 true DK0917460T3 (da) 2002-03-25

Family

ID=5464691

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97934627T DK0917460T3 (da) 1996-08-01 1997-07-31 Cyclosporin-formulering

Country Status (11)

Country Link
US (2) US6106860A (es)
EP (1) EP0917460B1 (es)
KR (1) KR100495417B1 (es)
AT (1) ATE213643T1 (es)
AU (1) AU3777197A (es)
CZ (1) CZ288739B6 (es)
DE (1) DE69710732T2 (es)
DK (1) DK0917460T3 (es)
ES (1) ES2171976T3 (es)
PT (1) PT917460E (es)
WO (1) WO1998005309A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5858401A (en) * 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
CZ288739B6 (cs) * 1996-08-01 2001-08-15 Galena, A. S. Cyklosporin obsahující léčivé přípravky
SE511313C2 (sv) * 1997-01-13 1999-09-06 Gs Dev Ab Komposition med reglerad frisättning innefattande fettsyraester av diacylglycerol
GB9811854D0 (en) * 1998-06-02 1998-07-29 Ciba Geigy Ag Organic compounds
AUPP627498A0 (en) 1998-10-02 1998-10-22 University Of Queensland, The Novel peptides - i
GB2355656B (en) * 1999-08-17 2004-04-07 Galena As Pharmaceutical compositions for oral and topical administration
WO2003032949A1 (en) * 2001-10-19 2003-04-24 Isotechnika Inc. Novel cyclosporin analog microemulsion preconcentrates
GB2391473B (en) * 2002-08-02 2004-07-07 Satishchandra Punambhai Patel Pharmaceutical compositions
EP2386566A3 (en) 2002-12-02 2012-02-15 Xenome Ltd Chi-conotoxin peptides (II)
PT1572725E (pt) 2002-12-02 2012-05-28 Xenome Ltd Péptidos de qui-conotoxina possuindo um ácido piroglutâmico n-terminal
KR100884189B1 (ko) * 2007-06-20 2009-02-18 심종원 치아세정수단의 탈부착이 가능한 샤워기

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4322826A1 (de) * 1993-07-08 1995-01-12 Galenik Labor Freiburg Gmbh Pharmazeutisches Präparat
CZ288631B6 (cs) * 1996-01-18 2001-08-15 Galena, A. S. Léčivé přípravky s obsahem cyklosporinu
CZ288739B6 (cs) * 1996-08-01 2001-08-15 Galena, A. S. Cyklosporin obsahující léčivé přípravky

Also Published As

Publication number Publication date
WO1998005309A1 (en) 1998-02-12
US6312721B1 (en) 2001-11-06
KR100495417B1 (ko) 2005-06-14
ES2171976T3 (es) 2002-09-16
CZ288739B6 (cs) 2001-08-15
DE69710732T2 (de) 2002-10-17
PT917460E (pt) 2002-07-31
US6106860A (en) 2000-08-22
DE69710732D1 (de) 2002-04-04
KR20000029746A (ko) 2000-05-25
EP0917460B1 (en) 2002-02-27
AU3777197A (en) 1998-02-25
CZ228996A3 (cs) 1998-02-18
EP0917460A1 (en) 1999-05-26
ATE213643T1 (de) 2002-03-15

Similar Documents

Publication Publication Date Title
ATE383169T1 (de) Komponente und zusammensetzungen zur verabreichung von wirkstoffen
HK1036931A1 (en) Pharmaceutical compositions containing compounds with activity for the enhancement of absorption of active ingredients.
PT750618E (pt) Derivados de oxazolidinona e composicoes farmaceuticas que os contem
TNSN00010A1 (fr) DIPHENYLUREE A SUBSTITUTION ω CARBOXYARYLE SERVANT D'INHIBUTEURS DE RAF KINASE.
ATE387430T1 (de) Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe
NO971889L (no) Forbindelser og sammensetninger for levering av aktive midler
BR9707233A (pt) Fenantridinas
PL347671A1 (en) Compounds and compositions for delivering active agents
IL140710A0 (en) Pulmonary delivery of active agents
ES2160640T3 (es) Nuevos (r)-5-carbamoil-8-fluoro-3-amino disustituido en n,n-3,4-dihidro-2h-1-benzopiranos.
ATE311373T1 (de) Oxadiazolverbindungen und -zusammensetzungen zur abgabe von wirkstoffen
ATE396967T1 (de) (5-(2-hydroxy-4-chlorbenzoyl)valeriansäure und deren salze, und zusammensetzungen zur zuführung von wirkstoffen, die diese verbindungen enthalten
DE69326776D1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
FI964285A (fi) Taksaanien luokkaan kuuluviin johdannaisiin perustuvat farmaseuttiset valmisteet
DK0917460T3 (da) Cyclosporin-formulering
DE69836678D1 (de) Chinolin- und chinazolinderivate als antagonisten des corticotropin freisetzenden faktors (crf)
ATE179164T1 (de) Hiv-proteaseinhibitoren
UA74388C2 (uk) Фармацевтичні композиції тизоксаніду і нітазоксаніду
GEP20032975B (en) Echinocandin Derivatives, Preparation Method and Pharmaceutical Composition
ES2091039T3 (es) Nuevos bis-fenil-hexenos.
DE3850044D1 (de) Azelastin-Embonat, Verfahren zu seiner Herstellung und pharmazeutische Zubereitungen, die als Wirkstoff Azelastin-Embonat enthalten.
NZ331374A (en) Phenanthridine compounds and pharmaceutical compositions thereof
HUP0100634A2 (hu) Pentaeritrit-tetranitrátot tartalmazó gyógyászati készítmények
IL139317A0 (en) Benzimdazole and benzoxazole derivatives and pharmaceutical compositions contining the same
DK0817643T3 (da) Forbindelser og præparater til administration af aktive midler